Hypertension in the (mRen-2)27 rat is not explained by enhanced kinetics of transgenic Ren-2 renin

Hypertension

Volumn 42, Issue 4 I, 2003, Pages 523-527

  Rong, Pei ^a   Campbell, Duncan J ^a   Skinner, Sandford L ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Angiotensinogen; Blood pressure; Hypertension, essential; Renin angiotensin system

Indexed keywords

ANGIOTENSIN; ANGIOTENSINOGEN; RENIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME KINETICS; ESSENTIAL HYPERTENSION; GENE EXPRESSION; MALE; MOUSE; NONHUMAN; PH; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TRANSGENIC ANIMAL;

ANGIOTENSINOGEN; ANIMALS; ANIMALS, GENETICALLY MODIFIED; DISEASE MODELS, ANIMAL; HYPERTENSION; KINETICS; MALE; MICE; MICE, INBRED BALB C; RATS; RATS, SPRAGUE-DAWLEY; RENIN; SPECIES SPECIFICITY;

EID: 0141928120     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000093383.18302.A7     Document Type: Article

References (42)

1. Mullins JJ, Peters J, Ganten D. Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature. 1990;344:541-544.
2. Zhao Y, Bader M, Kreutz R, Fernandez Alfonso M, Zimmermann F, Ganten U, Metzger R, Ganten D, Mullins JJ, Peters J. Ontogenetic regulation of mouse Ren-2d renin gene in transgenic hypertensive rats, TGR(mREN2)27. Am J Physiol. 1993;265:E699-E707.
3. Bader M, Zhao Y, Sander M, Lee MA, Bachmann J, Böhm M, Djavidani B, Peters J, Mullins JJ, Ganten D. Role of tissue renin in the pathophysiology of hypertension in TGR(mREN2)27 rats. Hypertension. 1992;19:681-686.
4. Peter J, Hilgers KF, Masur-Gluth C, Kreutz R. Role of the circulating renin-angiotensin system in the pathogenesis of hypertension in transgenic rats, TGR(mRen2)27. Clin Exp Hypertens. 1996;18:933-948.
5. Tokita Y, Franco-Saenz R, Mulrow PJ, Ganten D. Effects of nephrectomy and adrenalectomy on the renin-angiotensin system of transgenic rats TGR(mRen-2)27. Endocrinology. 1994;134:253-257.
6. Langheinrich M, Lee MA, Bohm M, Pinto YM, Ganten D, Paul M. The hypertensive Ren-2 transgenic rat TGR(mREN2)27 in hypertension research: characteristics and functional aspects. Am J Hypertens. 1996;9:506-512.
7. Bachmann S, Peters J, Engler E, Ganten D, Mullins J. Transgenic rats carrying the mouse renin gene: morphological characterization of a low-renin hypertension model. Kidney Int. 1992;41:24-36.
8. Moriguchi A, Brosnihan KB, Kumagai H, Ganten D, Ferrario CM. Mechanisms of hypertension in transgenic rats expressing the mouse Ren-2 gene. Am J Physiol. 1994;266:R1273-R1279.
9. Campbell DJ, Rong P, Kladis A, Rees B, Ganten D, Skinner SL. Angiotensin and bradykinin peptides in the TGR(mRen-2)27 rat. Hypertension. 1995;25:1014-1020.
10. Mitchell KD, Jacinto SM, Mullins JJ. Proximal tubular fluid, kidney and plasma levels of angiotensin II in hypertensive ren-2 transgenic rats. Am J Physiol. 1997;42:F246-F253.
11. Veniant M, Whitworth CE, Menard J, Sharp MG, Gonzales MF, Bruneval P, Mullins JJ. Developmental studies demonstrate age-dependent elevation of renin activity in TGR(mRen2)27 rats. Am J Hypertens. 1995;8:1167-1176.
12. Bohlender J, Menard J, Edling O, Ganten D, Luft FC. Mouse and rat plasma renin concentration and gene expression in (mRen2)27 transgenic rats. Am J Physiol. 1998;274:H1450-H1456.
13. Tokita Y, Franco-Saenz R, Reimann EM, Mulrow PJ. Hypertension in the transgenic rat TGR(mRen-2)27 may be due to enhanced kinetics of the reaction between mouse renin and rat angiotensinogen. Hypertension. 1994;23:422-427.
14. Poulsen K, Jacobsen J. Is angiotensinogen a renin inhibitor and not a substrate for renin? J Hypertens. 1986;4:64-69.
15. Gutkowska J, Corvol P, Figueiredo AFS, Inagami T, Bouhnik J, Genest J. Kinetic studies of rat renin and tonin on purified rat angiotensinogen. Can J Biochem Cell Biol. 1984;62:137-142.
16. Campbell DJ, Valentijn AJ, Condron R. Purification and amino-terminal sequence of rat kidney renin: evidence for a two-chain structure. J Hypertens. 1991;9:29-33.
17. Campbell DJ, Valentijn AJ. Identification of vascular renin-binding proteins by chemical cross-linking: inhibition of binding of renin by renin inhibitors. J Hypertens. 1994;12:879-890.
18. Matoba T, Murakami K, Inagami T. Rat renin: purification and characterization. Biochim Biophys Acta. 1978;526:560-571.
19. Figueiredo AF, Takii Y, Tsuji H, Kato K, Inagami T. Rat kidney renin and cathepsin D: purification and comparison of properties. Biochemistry. 1983;22:5476-5481.
20. Malling C, Poulsen K. Direct measurement of high molecular weight forms of renin in plasma. Biochim Biophys Acta. 1977;491:542-550.
21. Nexø E, Olsen PS, Poulsen K. Exocrine and endocrine secretion of renin and epidermal growth factor from the mouse submandibular glands. Regul Pept. 1984;8:327-334.
22. Ho S-C, Izumi H, Michelakis M. Purification and characterization of multiple forms of mouse submaxillary gland renin. Biochim Biophys Acta. 1982;717:405-413.
23. Misono KS, Holliday LA, Murakami K, Kuromizu K, Inagami T. Rapid and large-scale purification and characterization of renin from mouse submaxillary gland. Arch Biochem Biophys. 1982;217:574-581.
24. Rong P, Wilkinson-Berka JL, Skinner SL. Potassium control of extrarenal renin secretion in transgenic (mRen-2)27 and normal rats. Am J Physiol. 1999;277:E631-E638.
25. Weaver D, Skinner S, Walker L, Sangster M. Phenotypic inhibition of the renin-angiotensin system, emergence of the Ren-2 gene and adaptive radiation of mice. Gen Comp Endocrinol. 1991;83:305-315.
26. Devaux C, Menard J, Sicard P, Corvol P. Partial characterization of hog renin purified by affinity chromatography. Eur J Biochem. 1976;64:621-627.
27. Orth H, Krahe P, Steigelmann C, Gross F. Improved method for the determination of renin in rat kidneys. Pflugers Arch. 1971;329:125-135.
28. Whipp GT, Coghlan JP, Shulkes AA, Skinner SL, Wintour EM. Regulation of aldosterone in the rat: effect of oestrous cycle, pregnancy and sodium status. Aust J Exp Biol Med Sci. 1978;56:545-551.
29. Poulsen K, Jacobsen J. Enzyme reactions of the renin-angiotensin system. In: Robertson JIS, Nicholl MG, eds. The Renin-Angiotensin System. London, UK: Gower Medical Publishing; 1993.
30. Menard J, Clauser E, Bouhnik J, Corvol P. Angiotensinogen: biochemistry. In: Robertson JIS, Nicholl MG, eds. The Renin-Angiotensin System. London, UK: Gower Medical Publishing: 1993.
31. Rohrwasser A, Morgan T, Dillon HF, Zhao L, Callaway CW, Hillas E, Zhang S, Cheng T, Inagami T, Ward K, Terreros DA, Lalouel J-M. Elements of a paracrine tubular renin-angiotensin system along the entire nephron. Hypertension. 1999;34:1265-1274.
32. Kelly DJ, Skinner SL, Gilbert RE, Cox AJ, Cooper ME, Wilkinson-Berka JL. Effects of endothelin or angiotensin II receptor blockade on diabetes in the transgenic (mRen-2)27 rat. Kidney Int. 2000;57:1882-1894.
33. Kelly DJ. Tissue renin and the pathogenesis of diabetic complications in the hypertensive transgenic (mRen-2) rat. PhD thesis. Melbourne, Australia: University of Melbourne; 1998.
34. 2 receptors in the hypertensive Ren-2 gene transgenic rat kidney. Hypertension. 1999;33:347-353.
35. Navar LG, Harrison-Bernard LM. Intrarenal angiotensin II augmentation in angiotensin II dependent hypertension. Hypertens Res. 2000;23:291-301.
36. Gardiner SM, March JE, Kemp PA, Mullins JJ, Bennett T. Haemodynamic effects of losartan and the endothelin antagonist, SB 209670, in conscious transgenic (mRen-2)27 hypertensive rats. Br J Pharmacol. 1995;116:2237-2244.
37. Balakrishnan SM, Wang HD, Gopalakrishnan V, Wilson TM, McNeil JR. Effect of an endothelin antagonist on hemodynamic responses to angiotensin II. Hypertension. 1996;28:806-809.
38. Rossi GP, Pessina AC. Endothelin-1 in angiotensin II-dependent hypertension. Cardiovasc Res. 1999;44:450-451.
39. A-receptor antagonist. Circulation. 1997;96:1593-1597.
40. Campbell DJ, Kladis A, Skinner SL, Whitworth JA. Characterization of angiotensin peptides in plasma of anephric man. J Hypertens. 1991;9:265-274.
41. Danser AHJ, Derkx FHM, Schalekamp MADH, Hense H-W, Riegger AJ, Schunkert H. Determinants of individual variation of renin and prorenin concentrations: evidence for sexual dimorphism of (pro)renin levels in humans. J Hypertens. 1998;16:853-862.
42. Derkx FHM, Schalekamp MADH. Human prorenin: pathophysiology and clinical implications. Clin Exp Hypertens A. 1988;10:1213-1225.